2002
DOI: 10.1002/mds.10241
|View full text |Cite
|
Sign up to set email alerts
|

Ethnic differences in the expression of neurodegenerative disease: Machado‐Joseph disease in Africans and Caucasians

Abstract: We describe several families of African origin with SCA3/Machado-Joseph disease gene expansions. In these cases, the phenotype ranges from ataxia with parkinsonian signs to a syndrome clinically almost indistinguishable from idiopathic, L-dopa-responsive Parkinson's disease. In contrast, these parkinsonian phenotypes are rare in those of European descent. Haplotype analysis shows that these African families do not share a common founder, thus a cis-acting element in the promoter is unlikely to be responsible t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
39
0

Year Published

2003
2003
2019
2019

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 70 publications
(41 citation statements)
references
References 9 publications
2
39
0
Order By: Relevance
“…In the limited number of times this biological validation has been compared retrospectively against the clinical (and pathologic) characterization of neurological disease, it has become clear that the clinical characterization holds up poorly in different racial groups. For example, the phenotypes of both Spinocerebellar Ataxia types 2 and 3 (SCA2 and SCA3) are different in Eastern Asians and Sub-Saharan-Africans respectively from their phenotypes in Caucasians [10-13]. Dentatorubral-Pallidoluysian Atrophy in the Japanese is different from Haw River syndrome in African-Americans despite being caused by the same polyglutamine expansion [14,15].…”
Section: Textmentioning
confidence: 99%
“…In the limited number of times this biological validation has been compared retrospectively against the clinical (and pathologic) characterization of neurological disease, it has become clear that the clinical characterization holds up poorly in different racial groups. For example, the phenotypes of both Spinocerebellar Ataxia types 2 and 3 (SCA2 and SCA3) are different in Eastern Asians and Sub-Saharan-Africans respectively from their phenotypes in Caucasians [10-13]. Dentatorubral-Pallidoluysian Atrophy in the Japanese is different from Haw River syndrome in African-Americans despite being caused by the same polyglutamine expansion [14,15].…”
Section: Textmentioning
confidence: 99%
“…This clinical presentation, although common among patients of African extraction, is rare in families of European extraction. 10 The hypothesis of cis effects responsible for this variation has, however, been weakened by the absence of a haplotype shared by all families with type 4 MJD; instead, trans-acting genetic factors could explain this rare presentation in a restricted ethnic background. 10 The proband from a Nigerian family had, however, type 2 MJD with no Parkinsonian features.…”
Section: Discussionmentioning
confidence: 99%
“…10 The hypothesis of cis effects responsible for this variation has, however, been weakened by the absence of a haplotype shared by all families with type 4 MJD; instead, trans-acting genetic factors could explain this rare presentation in a restricted ethnic background. 10 The proband from a Nigerian family had, however, type 2 MJD with no Parkinsonian features. In general, heterogeneity of neurologic findings in MJD seems to be partly explained by duration of the disease, clinical type and CAG repeat length.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations